CLINICAL STUDIES
Acute and chronic tissue response to coronary stent implantation: pathologic findings in human specimen
Peter H. Grewe, MD*,
Thomas Deneke, MD*,
Abderrahman Machraoui, MD*,
J.ürgen Barmeyer, MD* and
Klaus-Michael Müller, MD
* Department of Cardiology and Angiology, University Hospital "Bergmannsheil," Bochum, Germany
Institute of Pathology, University Hospital "Bergmannsheil," Bochum, Germany
Manuscript received August 26, 1998;
revised manuscript received July 29, 1999,
accepted September 14, 1999.
Reprint requests and correspondence: Dr. Peter H. Grewe, Department of Cardiology and Angiology, University Hospital "Bergmannsheil" Bochum, Bürkle-de-la-Camp-Platz 1, 44789 Bochum, Germany
PeterGrewe{at}AOL.com
OBJECTIVES
The aim of our study was to analyze the cellular components of neointimal tissue regeneration after coronary stenting.
BACKGROUND
High restenosis rates are a major limiting factor of coronary stenting. To reduce the occurrence of restenoses, more insights into the mechanisms leading to proliferation and expression of extracellular matrix are necessary.
METHODS
Twenty-one autopsy cases with coronary stents implanted 25 h to 340 days before death were studied. The stented vessel segments were analyzed postmortem by light microscopy and immunohistochemical staining.
RESULTS
In the initial phase stents are covered by a thin multilayered thrombus. Alpha-actin–positive smooth muscle cells (SMCs) are found as the main cellular component of the neointimal tissue. Later (>6 weeks) extracellular matrix increases and fewer SMCs can be found. In every phase the SMC layers are loosely infiltrated by inflammatory cells (T lymphocytes). In the early postinterventional phase all endothelial cells are destroyed. The borderline between the vessel lumen and the vascular wall is constituted by a thin, membranous thrombus. Six weeks after stenting, SMCs form the vessel surface. Complete reendothelialization is first found 12 weeks after stenting.
CONCLUSIONS
Stent integration is a multifactorally triggered process with proliferating SMCs generating regenerative tissue. In the early phase predominantly thrombotic material can be observed at the site of stenting, followed by the invasion of SMCs, T lymphocytes and macrophages. The incidence of delayed reendothelializations and the occurrence of deep dissections may be associated with excessive SMC hyperplasia.
|
Abbreviations and Acronyms
| | CD | = cluster of differentiation | | IVUS | = intravascular ultrasound | | L-316 | = chromium-nickel-ferrum stainless steel | | SMC | = smooth muscle cell |
|
This article has been cited by other articles:
|
|
|
|
 
G. Niccoli, D. Schiavino, F. Belloni, G. Ferrante, G. La Torre, M. Conte, N. Cosentino, R. A. Montone, V. Sabato, F. Burzotta, et al.
Pre-intervention eosinophil cationic protein serum levels predict clinical outcomes following implantation of drug-eluting stents
Eur. Heart J.,
June 1, 2009;
30(11):
1340 - 1347.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. T. Newsome, M. A. Kutcher, and R. L. Royster
Coronary Artery Stents: Part I. Evolution of Percutaneous Coronary Intervention
Anesth. Analg.,
August 1, 2008;
107(2):
552 - 569.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Van der Heyden, M. J. Suttorp, E. T. Bal, J. M. Ernst, R. G. Ackerstaff, J. Schaap, J. C. Kelder, M. Schepens, and H. W. Plokker
Staged Carotid Angioplasty and Stenting Followed by Cardiac Surgery in Patients With Severe Asymptomatic Carotid Artery Stenosis: Early and Long-Term Results
Circulation,
October 30, 2007;
116(18):
2036 - 2042.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P.-G. Chassot, A. Delabays, and D. R. Spahn
Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction
Br. J. Anaesth.,
September 1, 2007;
99(3):
316 - 328.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. V. Finn, G. Nakazawa, M. Joner, F. D. Kolodgie, E. K. Mont, H. K. Gold, and R. Virmani
Vascular Responses to Drug Eluting Stents: Importance of Delayed Healing
Arterioscler Thromb Vasc Biol,
July 1, 2007;
27(7):
1500 - 1510.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Camenzind, P. G. Steg, and W. Wijns
A Cause for Concern
Circulation,
March 20, 2007;
115(11):
1440 - 1455.
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Tang, X. Chen, S. Tang, T. LaLonde, and J. M Gardin
Granulation encapsulated stent: a new therapeutic approach for vascular implantation
Heart,
February 1, 2007;
93(2):
238 - 243.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. E. Stahli, G. G. Camici, J. Steffel, A. Akhmedov, K. Shojaati, M. Graber, T. F. Luscher, and F. C. Tanner
Paclitaxel Enhances Thrombin-Induced Endothelial Tissue Factor Expression via c-Jun Terminal NH2 Kinase Activation
Circ. Res.,
July 21, 2006;
99(2):
149 - 155.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Joner, A. V. Finn, A. Farb, E. K. Mont, F. D. Kolodgie, E. Ladich, R. Kutys, K. Skorija, H. K. Gold, and R. Virmani
Pathology of Drug-Eluting Stents in Humans: Delayed Healing and Late Thrombotic Risk
J. Am. Coll. Cardiol.,
July 4, 2006;
48(1):
193 - 202.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Tsimikas
Drug-Eluting Stents and Late Adverse Clinical Outcomes: Lessons Learned, Lessons Awaited
J. Am. Coll. Cardiol.,
May 16, 2006;
47(10):
2112 - 2115.
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. J. Gomes and E. Buffolo
Coronary stenting and inflammation: implications for further surgical and medical treatment.
Ann. Thorac. Surg.,
May 1, 2006;
81(5):
1918 - 1925.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Dalainas, G. Nano, M. Randall, F. McKevitt, G. Venables, T. Cleveland, and P. Gaines
Compatibility of Carotid Stenting and Cardiac Surgery
Stroke,
May 1, 2006;
37(5):
1153 - 1154.
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Naruko, M. Ueda, S. Ehara, A. Itoh, K. Haze, N. Shirai, Y. Ikura, M. Ohsawa, H. Itabe, Y. Kobayashi, et al.
Persistent High Levels of Plasma Oxidized Low-Density Lipoprotein After Acute Myocardial Infarction Predict Stent Restenosis
Arterioscler Thromb Vasc Biol,
April 1, 2006;
26(4):
877 - 883.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. G. Touchard and R. S. Schwartz
Preclinical Restenosis Models: Challenges and Successes
Toxicol Pathol,
January 1, 2006;
34(1):
11 - 18.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. T. Murphy and B. G. Fahy
Thrombosis of Sirolimus-Eluting Coronary Stent in the Postanesthesia Care Unit
Anesth. Analg.,
October 1, 2005;
101(4):
971 - 973.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Steffel, R. A. Latini, A. Akhmedov, D. Zimmermann, P. Zimmerling, T. F. Luscher, and F. C. Tanner
Rapamycin, but Not FK-506, Increases Endothelial Tissue Factor Expression: Implications for Drug-Eluting Stent Design
Circulation,
September 27, 2005;
112(13):
2002 - 2011.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. H. Grewe, K. M. Muller, M. Lindstaedt, A. Germing, A. Muller, A. Mugge, and T. Deneke
Reaction Patterns of the Tracheobronchial Wall to Implanted Noncovered Metal Stents
Chest,
August 1, 2005;
128(2):
986 - 990.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. F. LaDisa Jr., Lars. E. Olson, R. C. Molthen, D. A. Hettrick, P. F. Pratt, M. D. Hardel, J. R. Kersten, D. C. Warltier, and P. S. Pagel
Alterations in wall shear stress predict sites of neointimal hyperplasia after stent implantation in rabbit iliac arteries
Am J Physiol Heart Circ Physiol,
May 1, 2005;
288(5):
H2465 - H2475.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. F. LaDisa Jr., L. E. Olson, I. Guler, D. A. Hettrick, J. R. Kersten, D. C. Warltier, and P. S. Pagel
Circumferential vascular deformation after stent implantation alters wall shear stress evaluated with time-dependent 3D computational fluid dynamics models
J Appl Physiol,
March 1, 2005;
98(3):
947 - 957.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Koch, J. Mehilli, A. Pfeufer, A. Schomig, and A. Kastrati
Apolipoprotein E gene polymorphisms and thrombosis and restenosis after coronary artery stenting
J. Lipid Res.,
December 1, 2004;
45(12):
2221 - 2226.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Toutouzas, A. Colombo, and C. Stefanadis
Inflammation and restenosis after percutaneous coronary interventions
Eur. Heart J.,
October 1, 2004;
25(19):
1679 - 1687.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Hibbert, Y.-X. Chen, and E. R. O'Brien
c-kit-Immunopositive vascular progenitor cells populate human coronary in-stent restenosis but not primary atherosclerotic lesions
Am J Physiol Heart Circ Physiol,
August 1, 2004;
287(2):
H518 - H524.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P H Grewe, T Deneke, C Hanefeld, and K-M Muller
Human coronary morphology after {beta} radiation brachytherapy of in-stent restenosis
Heart,
June 1, 2004;
90(6):
e32 - e32.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Marcucci, P.-G. Chassot, J.-P. Gardaz, L. Magnusson, H.-B. Ris, A. Delabays, and D. R. Spahn
Fatal myocardial infarction after lung resection in a patient with prophylactic preoperative coronary stenting{dagger}
Br. J. Anaesth.,
May 1, 2004;
92(5):
743 - 747.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Hoppmann, W. Koch, A. Schomig, and A. Kastrati
The 5A/6A polymorphism of the stromelysin-1 gene and restenosis after percutaneous coronary interventions
Eur. Heart J.,
February 2, 2004;
25(4):
335 - 341.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Fukuda, K. Shimada, A. Tanaka, T. Kawarabayashi, M. Yoshiyama, and J. Yoshikawa
Circulating monocytes and in-stent neointima after coronary stent implantation
J. Am. Coll. Cardiol.,
January 7, 2004;
43(1):
18 - 23.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Farb, A. P. Burke, F. D. Kolodgie, and R. Virmani
Pathological Mechanisms of Fatal Late Coronary Stent Thrombosis in Humans
Circulation,
October 7, 2003;
108(14):
1701 - 1706.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Eto, S. Biro, M. Miyata, H. Kaieda, H. Obata, T. Kihara, K. Orihara, and C. Tei
Angiotensin II type 1 receptor participates in extracellular matrix production in the late stage of remodeling after vascular injury
Cardiovasc Res,
July 1, 2003;
59(1):
200 - 211.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Gorchakova, W. Koch, N. von Beckerath, J. Mehilli, A. Schomig, and A. Kastrati
Association of a genetic variant of endothelial nitric oxide synthase with the 1 year clinical outcome after coronary stent placement
Eur. Heart J.,
May 1, 2003;
24(9):
820 - 827.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Egashira
Molecular Mechanisms Mediating Inflammation in Vascular Disease: Special Reference to Monocyte Chemoattractant Protein-1
Hypertension,
March 1, 2003;
41(3):
834 - 841.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Versaci, A. Gaspardone, F. Tomai, F. Ribichini, P. Russo, I. Proietti, A. S. Ghini, V. Ferrero, L. Chiariello, P. Agostino Gioffre, et al.
Immunosuppressive therapy for the prevention of restenosis after coronary artery stent implantation (IMPRESS study)
J. Am. Coll. Cardiol.,
December 4, 2002;
40(11):
1935 - 1942.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Yoshitomi, S. Kojima, M. Yano, Y. Matsumoto, T. Sugi, M. Saotome, K.-e Tanaka, M. Endo, and M. Kuramochi
Peristent Tissue Proliferation of Multilink Stents Is Dependent on Preprocedural Plaque Area: A Serial Intravascular Ultrasound Analysis
Angiology,
May 1, 2002;
53(3):
303 - 311.
[Abstract]
[PDF]
|
|
|
|
|
|
|
O. Masuo, T. Terada, G. Walker, M. Tsuura, H. Matsumoto, K. Tohya, M. Kimura, K. Nakai, and T. Itakura
Study of the Patency of Small Arterial Branches after Stent Placement with an Experimental in Vivo Model
AJNR Am. J. Neuroradiol.,
April 1, 2002;
23(4):
706 - 710.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. H. Brasen, A. Kivela, K. Roser, T. T. Rissanen, M. Niemi, F. C. Luft, K. Donath, and S. Yla-Herttuala
Angiogenesis, Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor-BB Expression, Iron Deposition, and Oxidation-Specific Epitopes in Stented Human Coronary Arteries
Arterioscler Thromb Vasc Biol,
November 1, 2001;
21(11):
1720 - 1726.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Suzuki, G. Kopia, S.-i. Hayashi, L. R. Bailey, G. Llanos, R. Wilensky, B. D. Klugherz, G. Papandreou, P. Narayan, M. B. Leon, et al.
Stent-Based Delivery of Sirolimus Reduces Neointimal Formation in a Porcine Coronary Model
Circulation,
September 4, 2001;
104(10):
1188 - 1193.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Windecker, I. Mayer, G. De Pasquale, W. Maier, O. Dirsch, P. De Groot, Y.-P. Wu, G. Noll, B. Leskosek, B. Meier, et al.
Stent Coating With Titanium-Nitride-Oxide for Reduction of Neointimal Hyperplasia
Circulation,
August 21, 2001;
104(8):
928 - 933.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. L. Kaluza, A. E. Raizner, W. Mazur, D. G. Schulz, J. M. Buergler, L. F. Fajardo, F. O. Tio, and N. M. Ali
Long-Term Effects of Intracoronary {beta}-Radiation in Balloon- and Stent-Injured Porcine Coronary Arteries
Circulation,
April 24, 2001;
103(16):
2108 - 2113.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Stefanadis, K. Toutouzas, E. Tsiamis, C. Stratos, M. Vavuranakis, I. Kallikazaros, D. Panagiotakos, and P. Toutouzas
Increased local temperature in human coronary atherosclerotic plaques: an independent predictor of clinical outcome in patients undergoing a percutaneous coronary intervention
J. Am. Coll. Cardiol.,
April 1, 2001;
37(5):
1277 - 1283.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
